Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06319703
Other study ID # 22-00634
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date March 31, 2028

Study information

Verified date March 2024
Source NYU Langone Health
Contact Lu Hu, PhD
Phone 646-501-3438
Email Lu.hu@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this IDEAL project is to examine the effectiveness and implementation process of the video-based Diabetes Self-Management Education and Support (DSMES) + community health worker (CHW) (hereafter: "IDEAL") intervention compared with a wait-list control group (hereafter: "CONTROL") to improve glycemic control among Chinese immigrants with Type 2 diabetes (T2D) in New York City (NYC). Participants will be randomized with equal allocation to one of the 2 groups. The IDEAL group will receive 1 DSMES brief video/week for 24 weeks delivered via text message. The CHW will assess participants' SDOH barriers to T2D care and link them to available resources in the community. The CONTROL group will continue to receive their usual care and at the end of the study, they will receive DSMES videos.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 270
Est. completion date March 31, 2028
Est. primary completion date October 31, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: Participants must: 1. self-identify as a Chinese immigrant; 2. be between 18-70 years old, 3. have a diagnosis of T2D in the medical record; 4. have had an appointment with a physician for routine T2D care within the past 12 months; 5. have a most recent HbA1c > or = 8%; 6. be willing to receive brief videos regarding T2D management, and 7. possess a smartphone or, if they do not have one, be willing and able to use a study smartphone. Exclusion Criteria: 1. unable or unwilling to provide informed consent; 2. unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment); 3. unwilling to accept randomization assignment; 4. is pregnant, plans to become pregnant in the next 6 months, or becomes pregnant during the study, or 5. is breastfeeding (e.g., they may have potential dietary restrictions).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Diabetes Self-Management Education and Support (DSMES) Videos
Text message-delivered video-based DSMES intervention.
Community Health Worker Support (CHW)
Assess participants' SDOH barriers to Type 2 diabetes care and link them to available resources in the community.

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (2)

Lead Sponsor Collaborator
NYU Langone Health Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Hemoglobin A1C (HbA1c) Test Scores Scores expressed as a percentage of red blood cells that have sugar-coated hemoglobin.
Patients with Type 2 Diabetes receive a HbA1c blood test at their doctors' office every 3-6 months as part of usual care; testing results will be abstracted from the medical record at the participant's health care facility to minimize participant burden.
Baseline, Month 6
Primary Change in Hemoglobin A1C (HbA1c) Test Scores Scores expressed as a percentage of red blood cells that have sugar-coated hemoglobin.
Patients with Type 2 Diabetes receive a HbA1c blood test at their doctors' office every 3-6 months as part of usual care; testing results will be abstracted from the medical record at the participant's health care facility to minimize participant burden.
Baseline, Month 12
Secondary Stanford Self-Efficacy for Diabetes Scale Score 8-item self-assessment of participants' confidence level in performing specific self-management behaviors. Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident).
The score is the mean of the 8 items (Range: 1-10); higher scores indicate greater self-efficacy.
Baseline
Secondary Stanford Self-Efficacy for Diabetes Scale Score 8-item self-assessment of participants' confidence level in performing specific self-management behaviors. Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident).
The score is the mean of the 8 items (Range: 1-10); higher scores indicate greater self-efficacy.
Month 6
Secondary Stanford Self-Efficacy for Diabetes Scale Score 8-item self-assessment of participants' confidence level in performing specific self-management behaviors. Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident).
The score is the mean of the 8 items (Range: 1-10); higher scores indicate greater self-efficacy.
Month 12
Secondary Summary of Diabetes Self-Care Activities (SDSCA) Score 11-item self-report questionnaire assessing participants' adherence to diabetes self-management behaviors. Participants select the number of days (0 to 7) in the past week they have performed the behavior.
The result is an average score between 0 and 7; higher scores indicate better diabetes self-management behavior.
Baseline
Secondary Summary of Diabetes Self-Care Activities (SDSCA) Score 11-item self-report questionnaire assessing participants' adherence to diabetes self-management behaviors. Participants select the number of days (0 to 7) in the past week they have performed the behavior.
The result is an average score between 0 and 7; higher scores indicate better diabetes self-management behavior.
Month 6
Secondary Summary of Diabetes Self-Care Activities (SDSCA) Score 11-item self-report questionnaire assessing participants' adherence to diabetes self-management behaviors. Participants select the number of days (0 to 7) in the past week they have performed the behavior.
The result is an average score between 0 and 7; higher scores indicate better diabetes self-management behavior.
Month 12
Secondary Starting the Conversation (STC) Diet Scale Score 8-item self-report questionnaire measuring dietary behaviors. Scores range from 0 to 16; higher scores indicate more dietary behaviors that are not consistent with health. Baseline
Secondary Starting the Conversation (STC) Diet Scale Score 8-item self-report questionnaire measuring dietary behaviors. Scores range from 0 to 16; higher scores indicate more dietary behaviors that are not consistent with health. Month 6
Secondary Starting the Conversation (STC) Diet Scale Score 8-item self-report questionnaire measuring dietary behaviors. Scores range from 0 to 16; higher scores indicate more dietary behaviors that are not consistent with health. Month 12
Secondary National Cancer Institute Dietary Screener Questionnaire Score 27-item self-assessment of frequency of consumption of selected foods and drinks over the past month.
The scoring procedure converts responses to estimates of individual dietary intake for: Fruits and Vegetables (cup equivalents); Dairy (cup equivalents); Added Sugars (teaspoon equivalents); Whole Grains (ounce equivalents); Fiber (grams); and Calcium (milligrams). Higher scores indicate higher consumption of the food item.
Baseline
Secondary National Cancer Institute Dietary Screener Questionnaire Score 27-item self-assessment of frequency of consumption of selected foods and drinks over the past month.
The scoring procedure converts responses to estimates of individual dietary intake for: Fruits and Vegetables (cup equivalents); Dairy (cup equivalents); Added Sugars (teaspoon equivalents); Whole Grains (ounce equivalents); Fiber (grams); and Calcium (milligrams). Higher scores indicate higher consumption of the food item.
Month 6
Secondary National Cancer Institute Dietary Screener Questionnaire Score 27-item self-assessment of frequency of consumption of selected foods and drinks over the past month.
The scoring procedure converts responses to estimates of individual dietary intake for: Fruits and Vegetables (cup equivalents); Dairy (cup equivalents); Added Sugars (teaspoon equivalents); Whole Grains (ounce equivalents); Fiber (grams); and Calcium (milligrams). Higher scores indicate higher consumption of the food item.
Month 12
Secondary International Physical Activity Questionnaire (IPAQ) Short-Version Score Self-assessment providing an estimate of the number of minutes per week participants engage in three categories of physical activity: vigorous activity, moderate activity, and walking activity.
Results are expressed in metabolic equivalent (MET) minutes per week. MET minutes represent the amount of energy expended carrying out physical activity.
The formula for calculating MET is as follows: 8(vigorous activity)(minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes) = MET.
Higher scores indicate higher weekly levels of physical activity.
Baseline
Secondary International Physical Activity Questionnaire (IPAQ) Short-Version Score Self-assessment providing an estimate of the number of minutes per week participants engage in three categories of physical activity: vigorous activity, moderate activity, and walking activity.
Results are expressed in metabolic equivalent (MET) minutes per week. MET minutes represent the amount of energy expended carrying out physical activity.
The formula for calculating MET is as follows: 8(vigorous activity)(minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes) = MET.
Higher scores indicate higher weekly levels of physical activity.
Month 6
Secondary International Physical Activity Questionnaire (IPAQ) Short-Version Score Self-assessment providing an estimate of the number of minutes per week participants engage in three categories of physical activity: vigorous activity, moderate activity, and walking activity.
Results are expressed in metabolic equivalent (MET) minutes per week. MET minutes represent the amount of energy expended carrying out physical activity.
The formula for calculating MET is as follows: 8(vigorous activity)(minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes) = MET.
Higher scores indicate higher weekly levels of physical activity.
Month 12
See also
  Status Clinical Trial Phase
Completed NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum N/A
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Active, not recruiting NCT05566847 - Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Completed NCT04965506 - A Study of IBI362 in Chinese Patients With Type 2 Diabetes Phase 2
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Active, not recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Recruiting NCT06010004 - A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Phase 3
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A